Publications by authors named "Craig Coleman"

Claim this Profile
M
Methods of identifying transthyretin amyloid cardiomyopathy in secondary data sources: a systematic review.
Craig I Coleman, Randy Martinez, Sophia A Torres

Curr Med Res Opin· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Changes in SGLT2 Inhibitor and GLP-1 Receptor Agonist Use in Patients with Chronic Kidney Disease and Type 2 Diabetes, 2012-2023: A US Cohort Study.
Catherine B Johannes, Craig I Coleman, Csaba P Kovesdy, Anam M Khan, Ryan Ziemiecki

Diabetes Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-administration of triazoles with calcineurin or mammalian target of rapamycin inhibitors in solid organ transplant patients hospitalized with invasive aspergillosis.
Barbara Alexander, Melissa D Johnson, Belinda Lovelace, Craig I Coleman

J Antimicrob Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspergillosis-Attributable Mortality in the United States: Analysis of Death Certificate Data.
Thomas J Walsh, Dakota Sicignano, Matthew Mastropietro, Belinda Lovelace, Craig I Coleman

Clin Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of olorofim in the treatment of invasive aspergillosis in patients with limited suitable alternative treatment options: a US payer perspective.
Thomas J Walsh, Craig I Coleman, Rob Blissett, Thibaud Prawitz, Giuseppe Bonetti

Antimicrob Agents Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Venous Thromboembolism Patients with Comorbid Obstructive Sleep Apnea: A Retrospective Cohort Study.
Craig I Coleman, Nitesh Sood, Cindy Chen, Alicia K Campbell, Veronica Ashton

Clin Appl Thromb Hemost· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coccidioidomycosis-Attributable Death in the United States: An Analysis of Cases Reported on Death Certificates, 2018-2023.
Huiqiao Fan, Fariba Donovan, Belinda Lovelace, Craig I Coleman

J Fungi (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An External Control Arm for the Oral Factor XIa Inhibitor Asundexian Phase 2 Trial in Atrial Fibrillation (PACIFIC-AF) Using Electronic Health Records.
Tatsiana Vaitsiakhovich, Alexander Hartenstein, Stephen Privitera, Manesh R Patel, Jonathan P Piccini, Craig I Coleman

Cardiol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Resource Utilization, Treatment Costs, and Mortality in Patients with Malignancies or Transplantation Who Develop Invasive Aspergillosis.
Thomas J Walsh, Craig I Coleman, Melissa Johnson, Belinda Lovelace, Barbara D Alexander

J Fungi (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Misuse of the unspecified coccidioidomycosis diagnosis code: An audit of electronic health records.
Craig I Coleman, Sherry Danese, Julie Ulloa, Mark Bresnik, Belinda Lovelace

Med Mycol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease.
J Bradley Layton, Ryan Ziemiecki, Catherine B Johannes, Manel Pladevall-Vila, Anam M Khan, Craig I Coleman

Diabetes Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antifungal therapy patterns, healthcare utilization, costs, and mortality in central nervous system and non-central nervous system disseminated coccidioidomycosis across the continuum-of-care.
Fariba Donovan, Mark Bresnik, Belinda Lovelace, Lia Pizzicato, Vamshi Ruthwik Anupindi, Craig I Coleman

Clin Microbiol Infect· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study.
Manel Pladevall-Vila, Ryan Ziemiecki, Catherine B Johannes, Anam M Khan, Daniel Mines, Craig I Coleman

Diabetes Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study.
Catherine B Johannes, Ryan Ziemiecki, Manel Pladevall-Vila, Natalie Ebert, Csaba P Kovesdy, Craig I Coleman

Diabetes Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Burden of Hospital Illness Associated with Disseminated Versus Isolated Pulmonary Coccidioidomycosis in the United States.
Craig I Coleman, Jessica Bylyku, Andria Latifi, Belinda Lovelace, Ryan Shan

J Fungi (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between the Need to Change Initial Antifungal Therapy and Treatment Costs in Patients With Invasive Aspergillosis.
Barbara D Alexander, Melissa Johnson, Mark Bresnik, Vamshi Ruthwik Anupindi, Lia Pizzicato, Craig I Coleman

Open Forum Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world andexanet alfa utilization and the association between delay in administration due to hospital transfer and all-cause inpatient mortality.
Huiqiao Fan, Youssef Bessada, Craig I Coleman

Res Pract Thromb Haemost· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of factor Xa inhibitor-related traumatic non-intracranial bleeding events with andexanet alfa or four-factor prothrombin complex concentrate in a US multicenter observational study.
Paul P Dobesh, Craig I Coleman, Mark Danese, Eva Lesén, Raymond C Chang

J Am Coll Emerg Physicians Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Hospitalization for Coccidioidal Meningitis: An Analysis of the National Inpatient Sample, 2019-2021.
Craig I Coleman, Fariba Donovan, Lahar Miriyapalli, Ryan Shan, Belinda Lovelace

Open Forum Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Antifungal Therapy Patterns Across the Continuum of Care in United States Adults with Invasive Aspergillosis.
Barbara D Alexander, Melissa Johnson, Mark Bresnik, Vamshi Ruthwik Anupindi, Lia Pizzicato, Craig I Coleman

J Fungi (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study.
Marie Linder, Anders Ekbom, Gunnar Brobert, Kai Vogtländer, Yanina Balabanova, Craig I Coleman

J Thromb Thrombolysis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis.
C Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V Hernandez, William L Baker, Craig I Coleman

Pharmacotherapy· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using 30-day modified rankin scale score to predict 90-day score in patients with intracranial hemorrhage: Derivation and validation of prediction model.
William L Baker, Mukul Sharma, Alexander Cohen, Mario Ouwens, Mary J Christoph, Craig I Coleman

PLoS One· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "Letter to Dobesh et al. on lower mortality with andexanet alfa in factor Xa inhibitor-related major bleeding".
Paul P Dobesh, Gregory J Fermann, Mary J Christoph, Bruce Koch, Eva Lesén, Craig I Coleman

Res Pract Thromb Haemost· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban vs Vitamin K Antagonist in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.
Reinhold Kreutz, Gilbert Deray, Jürgen Floege, Marianne Gwechenberger, Kai Hahn, Craig I Coleman

JACC Adv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis